dichlororibofuranosylbenzimidazole has been researched along with Carcinoma, Anaplastic in 3 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pautz, A | 1 |
| Linker, K | 1 |
| Hubrich, T | 1 |
| Korhonen, R | 1 |
| Altenhöfer, S | 1 |
| Kleinert, H | 1 |
| Wang, J | 1 |
| Gong, S | 1 |
| Fu, Y | 1 |
| Xue, Q | 1 |
| Chen, G | 1 |
| Liu, Y | 1 |
| Ree, AH | 1 |
| Knutsen, HK | 1 |
| Landmark, BF | 1 |
| Eskild, W | 1 |
| Hansson, V | 1 |
3 other studies available for dichlororibofuranosylbenzimidazole and Carcinoma, Anaplastic
| Article | Year |
|---|---|
The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression.
Topics: Carcinoma; Cell Line; Cell Line, Tumor; Colonic Neoplasms; Cytokines; Dichlororibofuranosylbenzimida | 2006 |
Effect of DRB on the biological characteristics of human laryngeal carcinoma Hep-2 cell line.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Collagen; Dichlor | 2007 |
Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis. Is hormonal control of ER mRNA degradation mediated by an RNA molecule?
Topics: Breast Neoplasms; Carcinoma; Cycloheximide; Dactinomycin; Dichlororibofuranosylbenzimidazole; Hormon | 1992 |